Sale!

Immunohistochemistry CD163 Test

Original price was: $126.Current price is: $88.

-30%

The Immunohistochemistry CD163 Test is a specialized diagnostic procedure that detects CD163 protein expression in tissue samples, primarily used for cancer diagnosis and prognosis assessment. This advanced immunohistochemistry test identifies tumor-associated macrophages, which play crucial roles in tumor microenvironment and cancer progression. The test helps oncologists determine tumor aggressiveness, predict treatment response, and guide personalized cancer therapy decisions. Patients with suspected cancers, abnormal biopsy findings, or those requiring treatment monitoring benefit from this precise diagnostic tool. At only $88 USD, this test provides valuable insights into cancer biology and helps optimize treatment strategies for better patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry CD163 Test: Advanced Cancer Diagnosis and Prognosis

Understanding the Immunohistochemistry CD163 Test

The Immunohistochemistry CD163 Test represents a cutting-edge diagnostic approach in modern oncology, utilizing sophisticated immunohistochemistry techniques to detect and quantify CD163 protein expression in tissue samples. This specialized test plays a pivotal role in cancer diagnosis, prognosis assessment, and treatment planning by identifying specific cellular markers that influence tumor behavior and treatment response.

What Does the CD163 Test Measure?

The Immunohistochemistry CD163 Test specifically detects the presence and distribution of CD163 protein, a hemoglobin scavenger receptor predominantly expressed on macrophages. This test provides crucial information about:

  • Tumor-associated macrophage density and distribution
  • Macrophage polarization status within tumor microenvironment
  • Immune cell infiltration patterns in cancerous tissues
  • Potential for angiogenesis and tumor progression
  • Response prediction to various cancer therapies

Clinical Applications and Who Should Consider This Test

Primary Clinical Indications

The Immunohistochemistry CD163 Test is particularly valuable for patients with:

  • Suspected or confirmed cancer diagnoses requiring detailed characterization
  • Complex tumor cases needing comprehensive immune profiling
  • Previous inconclusive biopsy results requiring additional markers
  • Monitoring treatment response and disease progression
  • Assessing prognosis and determining appropriate therapeutic approaches

Symptoms and Conditions Warranting Testing

Patients experiencing unexplained symptoms or having specific medical conditions may benefit from this test, including:

  • Unexplained masses or tumors detected through imaging
  • Abnormal biopsy findings requiring further characterization
  • Cancer patients undergoing treatment monitoring
  • Individuals with family history of aggressive cancers
  • Patients with recurrent or treatment-resistant cancers

Benefits of Immunohistochemistry CD163 Testing

Choosing the Immunohistochemistry CD163 Test offers numerous advantages for comprehensive cancer care:

  • Precise Diagnosis: Provides detailed information about tumor microenvironment composition
  • Prognostic Insights: Helps predict disease progression and patient outcomes
  • Treatment Guidance: Informs personalized treatment strategies based on immune profile
  • Monitoring Capability: Enables tracking of treatment response over time
  • Comprehensive Assessment: Complements other diagnostic methods for complete evaluation

Understanding Your Test Results

Interpretation Guidelines

Your Immunohistochemistry CD163 Test results will be carefully analyzed by our expert pathologists and oncologists. Results typically indicate:

  • CD163 Expression Levels: The intensity and distribution of CD163 staining in tissue samples
  • Macrophage Density: Quantitative assessment of tumor-associated macrophages
  • Spatial Distribution: Pattern of immune cell infiltration within tumor tissue
  • Clinical Correlation: Integration with other diagnostic findings and patient history

What Your Results Mean

Our medical team will provide comprehensive interpretation of your results, explaining:

  • How CD163 expression relates to your specific cancer type
  • Prognostic implications based on macrophage infiltration patterns
  • Potential treatment implications and therapeutic recommendations
  • Next steps for ongoing monitoring and management

Test Pricing and Availability

Test Description Regular Price Discount Price
Immunohistochemistry CD163 Test $126 USD $88 USD

Turnaround Time

  • Sample Submission: Daily by 6 PM
  • Report Timeline: Block: 5 days | Tissue Biopsy: 5 days | Tissue Large Complex: 7 days

Sample Requirements

For accurate testing, please provide:

  • Tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block
  • Ship at room temperature
  • Copy of Histopathology report
  • Site of biopsy information
  • Complete clinical history

Nationwide Availability

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Book Your Immunohistochemistry CD163 Test Today

Take the next step in comprehensive cancer diagnosis and management. Our experienced team is ready to assist you with scheduling, sample collection guidance, and result interpretation. Contact us today to schedule your test and gain valuable insights into your health status.

Call or WhatsApp: +1(267) 388-9828

Our dedicated healthcare professionals are available to answer your questions, discuss testing options, and help you understand how the Immunohistochemistry CD163 Test can benefit your specific situation. Don’t wait – take control of your health journey with advanced diagnostic testing from General Genetics Corporation.